<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The six genes encoding the Epstein-Barr virus nuclear antigens (EBNAs) are transcribed from one of two promoters, BamHI C promoter (Cp) or BamHI W promoter (Wp), located near the left end of the <z:mp ids='MP_0001799'>viral</z:mp> genome </plain></SENT>
<SENT sid="1" pm="."><plain>During the establishment of <z:mp ids='MP_0001799'>viral</z:mp> latency in B lymphocytes, Wp is used exclusively before a switch to Cp usage </plain></SENT>
<SENT sid="2" pm="."><plain>We and others have previously identified an enhancer in the region upstream of Cp which requires EBNA 2 for activity (M </plain></SENT>
<SENT sid="3" pm="."><plain>Woisetschlaeger, X </plain></SENT>
<SENT sid="4" pm="."><plain>W </plain></SENT>
<SENT sid="5" pm="."><plain>Jin, C </plain></SENT>
<SENT sid="6" pm="."><plain>N </plain></SENT>
<SENT sid="7" pm="."><plain>Yandava, L </plain></SENT>
<SENT sid="8" pm="."><plain>A </plain></SENT>
<SENT sid="9" pm="."><plain>Furmanski, J </plain></SENT>
<SENT sid="10" pm="."><plain>L </plain></SENT>
<SENT sid="11" pm="."><plain>Strominger, and S </plain></SENT>
<SENT sid="12" pm="."><plain>H </plain></SENT>
<SENT sid="13" pm="."><plain>Speck, Proc </plain></SENT>
<SENT sid="14" pm="."><plain>Natl </plain></SENT>
<SENT sid="15" pm="."><plain>Acad </plain></SENT>
<SENT sid="16" pm="."><plain>Sci </plain></SENT>
<SENT sid="17" pm="."><plain>USA 88:3942-3946, 1991; N </plain></SENT>
<SENT sid="18" pm="."><plain>S </plain></SENT>
<SENT sid="19" pm="."><plain>Sung, S </plain></SENT>
<SENT sid="20" pm="."><plain>Kenney, D </plain></SENT>
<SENT sid="21" pm="."><plain>Gutsch, and J </plain></SENT>
<SENT sid="22" pm="."><plain>S </plain></SENT>
<SENT sid="23" pm="."><plain>Pagano, J </plain></SENT>
<SENT sid="24" pm="."><plain>Virol </plain></SENT>
<SENT sid="25" pm="."><plain>65:2164-2169, 1991) </plain></SENT>
<SENT sid="26" pm="."><plain><z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">Infection</z:e> of B lymphocytes with a mutant virus lacking the EBNA 2 gene results in prolonged usage of Wp and failure to switch to Cp usage, indicating that EBNA 2 transactivation of the enhancer upstream of Cp may be critical for promoter switching </plain></SENT>
<SENT sid="27" pm="."><plain>In this study, we have defined the minimal EBNA 2-dependent enhancer by using a series of deletion mutants </plain></SENT>
<SENT sid="28" pm="."><plain>The results of site-directed mutagenesis revealed that there are three regions of the enhancer that are important for activity, two of which appear to bind B-lymphocyte-specific factors </plain></SENT>
</text></document>